Sabine Mueller, MD, PhD
Director, Pediatric Neuro-Oncology
Specialties: Pediatric brain tumors, including therapeutic studies and late effect studies
Dr. Mueller is a pediatric neuro-oncologist who specializes in caring for children with brain tumors and related genetic syndromes. In addition to clinical care, Dr. Mueller has extensive experience in clinical research methodology, and is involved in numerous clinical trials.
She is a co-founder and project leader of the Pacific Pediatric Neuro-Oncology Consortium, which is a network of children's hospitals focused on clinical trials of personalized medicine – therapies that are specific to the biology of each patient’s tumor.
1995: MS, University of Hamburg, Germany
2003: MD/PhD, University of Hamburg
2005: Internship, Pediatrics, Harvard Medical School
2006: Residency in Pediatrics, Harvard Medical School
2008: Chief Resident, Department of Neurology, UCSF
2009: Clinical Fellow, Child Neurology, UCSF
2010: Clinical Fellow, Neuro-Oncology, UCSF
2010-Present: Assistant Professor of Clinical Pediatrics and Neurosurgery, UCSF
2011-Present: UCSF Director Multi-Disciplinary Brain Tumor Clinic
2012-2015: Co-Project Leader Pacific Pediatric Neuro-Oncology Consortium (PNOC)
2013-Present: UCSF Director of the Pediatric Brain Tumor Center, Department of Neurology, Neurosurgery and Pediatrics
2015-Present: Project Leader PNOC
2017-Present: Associate Division Chief, Child Neurology
2011: BRAIN SPORE Career Development Award
2012: Hellman Family Research Fellow
2012: University of California Cancer Coordinating Committee Award
2013: Award Winning Abstract Annual Meeting of the Society of Neuro-Oncology
2014: Nominee of UCSF Medical Center's Exceptional Physician Award
2017: UCSF Pediatric Fellow Mentorship Award
2017: UCSF Medical Center Exceptional Physician Award
Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis
Kline C, Felton E, Allen IE, Tahir P, Mueller S.
J Neurooncol. 2018 Mar;137(1):103-110. Epub 2017 Dec 4.
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model
Louis N, Liu S, He X, Drummond DC, Noble CO, Goldman S, Mueller S, Bankiewicz K, Gupta N, Hashizume R.
J Neurooncol. 2018 Feb;136(3):475-484.
BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas
Olow A, Mueller S, Yang X, Hashizume R, Meyerowitz J, Weiss W, Resnick AC, Waanders AJ, Stalpers LJ, Berger MS, Gupta N, James CD, Petritsch CK, Haas-Kogan DA.
Clin Cancer Res. 2016 Nov 1;22(21):5312-5321. Epub 2016 May 23.